Indonesia Pharmaceutical Consulting

YCP excels in pharmaceutical consulting in Indonesia, helping clients thrive within the country's competitive sector. With YCP's wide range of services and decades of experience, the firm provides hands-on support and leverages global insights to unlock growth opportunities in Indonesia’s market.

Indonesia Pharmaceutical Consulting

YCP Pharmaceutical Experts in Indonesia

Pharmaceutical experts in Indonesia

Indonesia is experiencing significant growth across numerous sectors, including Pharmaceuticals. The nation's emerging economy propels advancements, driving a robust Pharmaceutical industry increasingly attracting investors and innovators.

YCP offers exceptional Indonesia Pharmaceutical Consulting, leveraging the expertise of our global professionals and profound knowledge to deliver unparalleled drug development services. Our arguments enable businesses to overcome key market impediments, ensuring a seamless entry and sustainable growth in Indonesia's pharmaceutical landscape.

YCP emerges as a trusted consulting provider for companies aiming to excel in Indonesia's dynamic Pharmaceutical market. Our expertise instills confidence and yields success, making us the premier partner for endeavors in this thriving industry.

YCP in Numbers

YCP Holdings
Project Across Asia
Offices
Portfolio Businesses
Professionals

Unlocking Potential: Your Path to Excellence with Indonesia's Pharmaceutical Professionals

Pharma Growth Strategy

Pharma Growth Strategy

Indonesia's pharmaceutical sector thrives with YCP's strategic consulting, driving growth through tailored market analysis and regulatory guidance.

M&A Advisory

M&A Advisory

In Indonesia, YCP excels in pharmaceutical M&A advice, tailored strategies, and deep industry insights to guarantee client success in competitive markets.

Market Entry

Market Entry

With specialized insight, YCP guides seamless Indonesia pharmaceutical market entry, offering strategic consulting for regulatory compliance and local partnerships.

Therapeutic Area Insights

Therapeutic Area Insights

Prominently, YCP excels in delivering unparalleled consulting services tailored to the pharmaceutical industry in Indonesia.

Our Services

Marketing & Sales

Craft data-driven pharmaceutical marketing strategies and enhance Indonesia sales pipelines.

  • Branding & Brand Management
  • Product & Portfolio Management
  • Pricing
  • Digital Marketing
  • E-commerce
  • Customer Experience
  • Sales Channel Strategy
  • Digital Sales

Operations

Sure, here's a section for a pharmaceutical consulting service in Indonesia: ```json { "response": "Enhance pharmaceutical efficacy in Indonesia with expert regulatory and market landscape navigation." }

  • Project Management Office (PMO)
  • Growth Strategy Implementation
  • Operation Transformation
  • Manufacturing
  • Organization Design

Supply Chain Management

Boost inventory efficiency by tapping into Indonesia's diverse pharmaceutical networks.

  • Supply Chain
  • Digital Supply Chain
  • Procurement
  • Logistics

M&A, Transactions, and PMI

Streamline M&A, transactions, and PMI support, leveraging expert insights in Indonesia's pharma sector.

  • M&A Strategy
  • Divesstiture/Curb-out Strategy
  • M&A Target Scouting
  • Buyer/Investor Search
  • Commercial Due Diligence
  • M&A Execution (Buy-side & Sell-side Financial Advisory)
  • Valuation
  • Post-Merger Integration (PMI)
  • Value Creation
  • IPO PMO
  • Joint Venture
  • Corporate Venture Capital

Strategy

Strategically crafting transformative solutions to prescribe success for Indonesia's pharmaceutical leaders.

  • Business Strategy
  • Corporate Finance
  • Growth Opportunity Identification
  • New Business Development
  • Organization Strategy
  • Enterprise Risk Management
  • Asset/Project Risk Management
  • Digital Strategy
  • Strategic Partnership & Channel Strategy

Digital Transformation

Leveraging advanced analytics, we reshape Indonesian pharmaceutical landscapes to harness global innovations.

  • DX Vision
  • Digital Roadmap
  • CIO/CDO Support
  • System Architecture Design
  • DX PMO
  • Artificial Intelligence (AI)
  • Robotic Process Automation (RPA)
  • Big Data Analysis
  • IT Organization Design & Restructuring
  • IT Portfolio Management
  • Off-shore Development Centre Set-up

Public Services

Crafting tailored strategies for Indonesia's pharma sector to optimize regulations and operations.

  • Economic Development
  • Public Policy Development
  • E-Governance

Sustainability

YCP navigates the Indonesian pharmaceutical landscape to integrate sustainability at every operational level.

  • Sustainability Strategy & Implementation
  • Double Materiality
  • Decarbonization & Net-Zero Strategy
  • Climate Change Risks and Opportunities
  • Sustainability Due Diligence
  • Supply Chain Assessment
  • ESG Reporting
  • Investor Relations & Fundraising
  • Organization & Governance Design

Market Research

Providing nuanced insights and actionable strategies in Indonesia's pharmaceutical sector.

  • Market Landscape
  • Market Size
  • Industry Structure and Trend
  • Competitive Benchmark
  • Business Partner Search & Screening
  • B2B/B2C Customer Survey
  • Consumer Research

Navigating Pharmaceutical Sector in Indonesia

Regulatory Obstacles Hinder Growth

  • The Indonesian pharmaceutical market faces stringent regulations, requiring over 60% approval from various bodies, slowing innovation and new product launches considerably.
  • To navigate this, exploring regional partnerships may absorb regulatory costs. Shifting focus to biosimilar investments offers lucrative gains considering up to a 25% rise in demand.

Infrastructure Deficits Impact Distribution

  • Over 40% of the population lacks access to advanced pharmaceutical products due to inadequate infrastructure, impacting national health indices.
  • Improving distribution networks by investing in local collaborations with logistics for fluorescent deliveries boosts availability, increases coverage by up to 50%.

Booming Demand for OTC Medications

  • Indonesia's over-the-counter medication expenditure is forecast to rise by 7% annually, fuelled by a population increasingly managing minor health issues independently.
  • This burgeoning market requires efforts to maximize shelf space in urban areas where self-care products see a spike, targeting a consumer base expected to rise above 275 million.

Government Incentives for Research

  • The government is dedicating a 15% tax incentive to drive pharmaceutical research, significantly increasing sectoral R&D budget strength over the next five years.
  • Taking advantage of research funding means prioritizing scalable innovation, predicted to ramp benefits on high-investment ground-breaking therapies in Indonesia.

Our Clients

We have worked with more than 2000 companies throughout various industries.

0
1
2
3
4
5
6
7
8
9
10
11

What Our Clients Say About Us

"The systematic and detailed approach adopted by the YCP team has helped to provide an in-depth analysis of the specific businesses in the country we are interested to enter. Their findings and recommendations have helped us gain a better understanding and make strategic decisions on our business expansion plan in this specific emerging country. I am therefore happy to recommend YCP as a reliable partner to any company requiring research and consulting capabilities in the medical areas. "

Boston Scientific Asia Pacific

Channels Manager ASEAN

Boston Scientific Asia Pacific

"YCP made sure they had a thorough understanding of our business needs and objectives and focused on the key aspects of the Vietnam market that helped us with our market development strategies. Their analysis and recommendations provided us with clear insights into the decision of our strategic options. "

Teva Pharma

Managing Director Asia Pacific

Teva Pharma

Results Through Expertise: Case Studies

Learn how we help clients build and implement strategies
that drive sustainable growth in today’s complex business landscape.

Corporate Entity Restructuring Advisory and M&A Target Search

Client

Fortune 500 MNC leader in medical imaging

Area

Indonesia

Expertise Scope

Mergers & Acquisition PMO

Project Summary

Amid the parent company's restructuring, our client sought YCP's expertise in re-entry strategy and M&A target identification. With our in-depth analysis, we negotiated with two M&A targets for 100% acquisition, saving over EUR 100M in investments.

E-Commerce Website Development

Client

A Japanese medical equipment manufacturer

Area

Southeast Asia

Expertise Scope

Strategic Marketing

Project Summary

Our client needed support tapping into the Southeast Asian market and building an e-commerce channel.​ We created a market entry strategy in three countries, developed localised landing pages, and managed client campaigns to gain market access.

YCP in Media

Media
Media
Media
Media
Media
Media
Media
Media
Media
Media
Media
Media
YCP Partner Septian talks on Asian Business Review about how regulatory and education gaps hinder the growth of halal startups.

YCP Partner Septian talks on Asian Business Review about how regulatory and education gaps hinder the growth of halal startups.

Global Business Reports interviews YCP Partner Septian Waluyan on Indonesia's shifting market dynamics and investment potential.

Global Business Reports interviews YCP Partner Septian Waluyan on Indonesia's shifting market dynamics and investment potential.

IDX Channel features YCP Managing Partner Pilar Dieter and Partner Septian Waluyan on the role of commitment and technological advancements in reaching zero emissions.

IDX Channel features YCP Managing Partner Pilar Dieter and Partner Septian Waluyan on the role of commitment and technological advancements in reaching zero emissions.

Publications

Opportunities in Indonesia's Dairy Farming Industry: The Lowland  Advantage
AI in Healthcare Whitepaper
CRDMO Whitepaper
Employee Wellness in the Age of Healthtech

Meet Our Experts

Establish industry dominance with our experts and partners

Yuki Ishida

Yuki Ishida

Managing Partner

Nationality: Japanese

Region Coverage:

Asia, North America

Past Experience:

Goldman Sachs

Pilar Dieter

Pilar Dieter

Managing Partner

Nationality: American

Region Coverage:

Asia, North America

Past Experience:

Alaris Consulting

Shingo Kasumoto

Shingo Kasumoto

Managing Partner

Nationality: Japanese

Region Coverage:

Asia

Past Experience:

P&G

Takahiro Okawa

Takahiro Okawa

Partner

Nationality: Japanese

Region Coverage:

Japan, Singapore, Thailand, Vietnam, Indonesia

Past Experience:

Accenture, Rakuten

Septian Waluyan

Septian Waluyan

Partner

Nationality: Indonesian

Region Coverage:

Asia, Europe

Past Experience:

Bayer, Philips

Jatin Gulati

Jatin Gulati

Partner

Nationality: Indian

Region Coverage:

Asia

Past Experience:

McKinsey & Company, Accenture Strategy

laurt fihey

Laurent Fihey

Partner

Nationality: French

Region Coverage:

Europe, Asia, Middle East, Africa, North America, South America

Past Experience:

Arthur Andersen, Advancy

dhendy fadhillah

Dhendy Rizki Fadhillah

Partner

Nationality: Indonesian

Region Coverage:

Asia, Middle East, Africa

Past Experience:

PwC, ALTAMIS Intelligence & Excellence

Talk to Our Pharmaceutical Experts

Arrange a session with our experts to explore how YCP can assist you in addressing your business challenges.

YCP Group is the leading professional firm in Asia empowering excellence through diverse expertise:

  • YCP 
  • YCP Auctus
  • YCP Consus